Related Experiment Videos
Interleukin-13 in asthma
Marsha Wills-Karp1, Monica Chiaramonte
1Division of Immunobiology, Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. wildc7@cchmc.org
Current Opinion in Pulmonary Medicine
|December 12, 2002
Summary
Interleukin-13 (IL-13) is a key driver of allergic asthma, acting on airway cells rather than traditional immune pathways. Understanding IL-13 mechanisms offers new therapeutic targets for allergy and asthma.
Area of Science:
- Immunology
- Pulmonology
- Allergy Research
Background:
- Interleukin-13 (IL-13) is a critical regulator of allergic responses.
- IL-13 has been shown to be necessary and sufficient for inducing allergic asthma features in animal models.
- Human studies show strong associations between IL-13 levels, gene polymorphisms, and allergic disease correlates.
Purpose of the Study:
- To review the current understanding of IL-13's role in allergy and asthma pathogenesis.
- To explore novel mechanisms by which IL-13 mediates allergic disease features.
- To focus on emerging insights into IL-13's induction of asthma pathology.
Main Methods:
- Review of existing literature on IL-13 in allergic diseases.
- Analysis of studies investigating IL-13's cellular targets and pathways.
- Synthesis of recent findings on IL-13's role in asthma pathogenesis.
Main Results:
- IL-13 induces allergic responses primarily through effects on epithelial and smooth muscle cells.
- The role of IL-13 is increasingly understood to be independent of traditional Th2 cytokine effector pathways like eosinophils and IgE.
- Evidence supports IL-13 as a central mediator in the pathophysiology of allergic asthma.
Conclusions:
- IL-13 plays a pivotal role in the pathogenesis of allergic asthma.
- New paradigms suggest IL-13 acts directly on structural cells in the airways.
- Further research into IL-13 mechanisms may reveal new therapeutic strategies for asthma and allergic diseases.